3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma
7
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Recurrence
3
Neoplasms
2
Leukemia, B-Cell
2
Burkitt Lymphoma
2
Neoplasm, Residual
1
Mature B-Cell Malignancies
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
Bevacizumab
19
Paclitaxel
16
Carboplatin
12
pembrolizumab
11
liposomal doxorubicin
10
Cyclophosphamide
9
Specimen Handling
8
Gemcitabine
8
olaparib
7
fludarabine
7
Topotecan
7
Magnetic Resonance Spectroscopy
7
Taxes
5
Immunoglobulin G
5
Fulvestrant
5
Disulfides
5
niraparib
4
Oxaliplatin
4
Nivolumab
4
Biopsy
4
trastuzumab deruxtecan
3
palbociclib
3
mirvetuximab soravtansine
3
aldesleukin
3
Leucovorin
3
Fluorouracil
3
1-dodecylpyridoxal
3
ulixertinib
2
nilotinib
2
ipatasertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
obinutuzumab
×
30 days
×
Clear all
No trials found.